cardiovascularКардиоваскулярная терапия и профилактикаCardiovascular Therapy and Prevention1728-88002619-0125«SILICEA-POLIGRAF» LLC10.15829/1728-8800-2011-4-121-127cardiovascular-1908Research ArticleОБЗОРЫREVIEWSРефрактерная постинфарктная ишемия миокарда: возможности терапииRefractory post-infarction myocardial ischemia: treatment potentialРябовВ. В.RyabovV. V.

доцент, кафедры кардиологии ФПК и ППС

Томск

ОюнаровЭ. О.OyunarovE. O.

аспирант

Томск

oyunarov@cardio.tsu.ruМарковВ. А.MarkovV. A.

зав. кафедрой кардиологии

Томск

ГОУ ВПО Сибирский государственный медицинский университет РосздраваSiberian State Medical UniversityУчреждение РАМН НИИ кардиологии СО РАМНResearch Institute of Cardiology, Siberian Division of the Russian Academy of Medical Sciences201120082011104121127Copyright © Рябов В.В., Оюнаров Э.О., Марков В.А., 20112011Рябов В.В., Оюнаров Э.О., Марков В.А.Ryabov V.V., Oyunarov E.O., Markov V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://cardiovascular.elpub.ru/jour/article/view/1908

Лечение рецидивирующей постинфарктной ишемии миокарда, рефрактерной к терапии, является до конца не решенной проблемой. Применение агрессивной медикаментозной терапии ограничено и зачастую не эффективно. Таким пациентам по тем или иным причинам невозможно выполнить ЧКВ или АКШ. В настоящее время разрабатываются альтернативные методы лечения рефрактерной стенокардии. Однако использование последних изучено на пациентах, страдающих хронической стабильной стенокардией, что требует дальнейшего изучения у пациентов с ОКС.

The treatment of recurrent, refractory post-infarction myocardial ischemia remains an unresolved clinical problem. Aggressive pharmaceutical therapy has limited effectiveness, while percutaneous coronary intervention or coronary artery bypass graft surgery are not possible in these patients, due to various reasons. Currently, alternative methods for refractory angina treatment are being developed for patients with chronic stable angina. The potential of these methods in patients with acute coronary syndrome should be investigated in the future studies.

рецидивирующая постинфарктная ишемия миокардарефрактерная стенокардияострый инфаркт миокардаRecurrent post-infarction myocardial ischemiarefractory anginaacute myocardial infarctionReferencesХарченко В.И., Какорина Е.П., Корякин М.В. и др. Смертность от основных болезней системы кровообращения в России. РКЖ 2005; 1: 5-15.Харченко В.И., Какорина Е.П., Корякин М.В. и др. Смертность от основных болезней системы кровообращения в России. РКЖ 2005; 1: 5-15.Люсов В.А., Лебедев А.Ю., Петрова Е.В., и др. Рецидивирующие расстройства коронарного кровообращения при остром инфаркте миокарда. РКЖ 2006; 2: 88-93.Люсов В.А., Лебедев А.Ю., Петрова Е.В., и др. Рецидивирующие расстройства коронарного кровообращения при остром инфаркте миокарда. РКЖ 2006; 2: 88-93.Davies MJ. The pathophysiology of acute coronary syndromes. Heart 2000; 83: 361-6.Davies MJ. The pathophysiology of acute coronary syndromes. Heart 2000; 83: 361-6.Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. Circulation 2004; 110: е82-293.Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction. Circulation 2004; 110: е82-293.Иоселиани Д.Г., Роган С.В., Семитко С.П. Стентирование инфаркт-ответственной артерии в первые часы острого инфаркта миокарда: ближайшие и среднеотдаленные результаты. Интервенц кардиология 2003; 2: 24-9.Иоселиани Д.Г., Роган С.В., Семитко С.П. Стентирование инфаркт-ответственной артерии в первые часы острого инфаркта миокарда: ближайшие и среднеотдаленные результаты. Интервенц кардиология 2003; 2: 24-9.Константинова Е.В., Магнитский А.В., Шостак Н.А. Тромболитическая терапия у больных острым инфарктом миокарда. РФК 2006; 4: 58-62.Константинова Е.В., Магнитский А.В., Шостак Н.А. Тромболитическая терапия у больных острым инфарктом миокарда. РФК 2006; 4: 58-62.Чернецов В.А., Господаренко А.Л. Предикторы возникновения рецидивирующих расстройств коронарного кровообращения у больных крупноочаговым инфарктом миокарда после тромболитической терапии. РКЖ 1999; 6: 11-4.Чернецов В.А., Господаренко А.Л. Предикторы возникновения рецидивирующих расстройств коронарного кровообращения у больных крупноочаговым инфарктом миокарда после тромболитической терапии. РКЖ 1999; 6: 11-4.Armstrong PW, Yuling Fu, Wei-Ching Chang, et al. Acute Coronary Syndromes in the GUSTO-IIb Trial: Prognostic Insights and Impact of Recurrent Ischemia. Circulation 1998; 98: 1860-8.Armstrong PW, Yuling Fu, Wei-Ching Chang, et al. Acute Coronary Syndromes in the GUSTO-IIb Trial: Prognostic Insights and Impact of Recurrent Ischemia. Circulation 1998; 98: 1860-8.Gibson CM, Karha J, Murphy SA, et al. Early and LongTerm Clinical Outcomes Assocated With Reinfarction Following Fibrinolytic Administration in the Thrombolysis In Myocardial Infarction Trials. JACC 2003; 42: 7-16.Gibson CM, Karha J, Murphy SA, et al. Early and LongTerm Clinical Outcomes Assocated With Reinfarction Following Fibrinolytic Administration in the Thrombolysis In Myocardial Infarction Trials. JACC 2003; 42: 7-16.Bosch X, Theroux P, Waters DD, et al. Early postinfarction ischemia: clinical, angiographic, and prognostic, significance. Circulation 1987; 75: 988-95.Bosch X, Theroux P, Waters DD, et al. Early postinfarction ischemia: clinical, angiographic, and prognostic, significance. Circulation 1987; 75: 988-95.Addy JM, van Miltenburg-van Zijl, Simoons ML, et al. Incidence and Follow-Up of Braunwald subgroups in Unstable Angina Pectoris. JACC 1995; 25: 1286-92.Addy JM, van Miltenburg-van Zijl, Simoons ML, et al. Incidence and Follow-Up of Braunwald subgroups in Unstable Angina Pectoris. JACC 1995; 25: 1286-92.Predrag Erceg, Mladen Davidovic, Zorana Vasiljevic, et al. Long-Term Prognosis of Patients With Early Post-Infarction Angina. Circ J 2007; 71: 1530-3.Predrag Erceg, Mladen Davidovic, Zorana Vasiljevic, et al. Long-Term Prognosis of Patients With Early Post-Infarction Angina. Circ J 2007; 71: 1530-3.Кохан Е.П., Немытин Ю.В., Пайвин А.А. Нестабильная стенокардия Москва 2000.Кохан Е.П., Немытин Ю.В., Пайвин А.А. Нестабильная стенокардия Москва 2000.Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410-4.Braunwald E. Unstable angina. A classification. Circulation 1989; 80: 410-4.Всероссийское научное общество кардиологов. Диагностика и лечение больных острым инфарктом миокарда с подъемом сегмента ST ЭКГ. Национальные клинические рекомендации 2008; 240-326.Всероссийское научное общество кардиологов. Диагностика и лечение больных острым инфарктом миокарда с подъемом сегмента ST ЭКГ. Национальные клинические рекомендации 2008; 240-326.Thygesen K, Alpert JS, Harvey D. Universal Definition of Myocardial Infarction. JACC 2007; 50: 2173-95.Thygesen K, Alpert JS, Harvey D. Universal Definition of Myocardial Infarction. JACC 2007; 50: 2173-95.Бурова Н.Н., Козулин В.Ю., Шляхто Е.В. Ранняя постинфарктная стенокардия. Сердце 2003; 2: 72-4.Бурова Н.Н., Козулин В.Ю., Шляхто Е.В. Ранняя постинфарктная стенокардия. Сердце 2003; 2: 72-4.Rozenberg VD, Nepomnyashchikh LM. Pathomorphology of Postinfarction Myocardial Ischemia during Atherosclerotic Obstruction of Coronary Arteries. Bull Exper Biol Med 2005; 3: 363-8.Rozenberg VD, Nepomnyashchikh LM. Pathomorphology of Postinfarction Myocardial Ischemia during Atherosclerotic Obstruction of Coronary Arteries. Bull Exper Biol Med 2005; 3: 363-8.Conti CR. The management of refractory angina. Eur Heart J 2000; 21: 1909-10.Conti CR. The management of refractory angina. Eur Heart J 2000; 21: 1909-10.Лупанов В.П. Диагностика и лечение рефрактерной стенокардии. РМЖ 2004; 2: 104-8.Лупанов В.П. Диагностика и лечение рефрактерной стенокардии. РМЖ 2004; 2: 104-8.Mannheimer C, Camici P, Chester MR, et al. The problem of chronic refractory angina. Report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J 2002; 23: 355-70.Mannheimer C, Camici P, Chester MR, et al. The problem of chronic refractory angina. Report from the ESC Joint Study Group on the Treatment of Refractory Angina. Eur Heart J 2002; 23: 355-70.Преображенский Д.В., Вышинская И.Д., Патарая С.А. и др. Антагонист кальция 3 поколения амлодипин: особенности клинической фармакологии и терапевтическое применение. РМЖ 2008; 11: 1524-31.Преображенский Д.В., Вышинская И.Д., Патарая С.А. и др. Антагонист кальция 3 поколения амлодипин: особенности клинической фармакологии и терапевтическое применение. РМЖ 2008; 11: 1524-31.Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction. JACC 2007; 50: 1-157.Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction. JACC 2007; 50: 1-157.Kim MC, Kini A, Sharma SK. Refractory Angina Pectoris. Mechanism and Therapeutic Options. JACC 2002; 39: 923-34.Kim MC, Kini A, Sharma SK. Refractory Angina Pectoris. Mechanism and Therapeutic Options. JACC 2002; 39: 923-34.Новикова Н.А., Гиляров М.Ю. Антитромботическая терапия при остром коронарном синдроме с подъемом сегмента ST. РМЖ 2008; 11: 1616-20.Новикова Н.А., Гиляров М.Ю. Антитромботическая терапия при остром коронарном синдроме с подъемом сегмента ST. РМЖ 2008; 11: 1616-20.Косарев В.В., Бабанов С.А. Антиагреганты: клинико-фармакологические подходы к применению при ишемической болезни сердца. РМЖ 2009; 18: 1172-6.Косарев В.В., Бабанов С.А. Антиагреганты: клинико-фармакологические подходы к применению при ишемической болезни сердца. РМЖ 2009; 18: 1172-6.Белоусов Ю.Б. Эффекты аторвастатина при остром коронарном синдроме: предупреждение ранних повторных ишемических исходов. Фарматека 2001; 11: 27-30.Белоусов Ю.Б. Эффекты аторвастатина при остром коронарном синдроме: предупреждение ранних повторных ишемических исходов. Фарматека 2001; 11: 27-30.Затейщиков Д.А., Королева О.С. Применение статинов в раннем периоде ОКС. Сердце 2008; 2: 85-90.Затейщиков Д.А., Королева О.С. Применение статинов в раннем периоде ОКС. Сердце 2008; 2: 85-90.Madsen JK, Grande P, Saunamßki K, et al. Danish Multicenter Randomized Study of Invasive Versus Conservative Treatment in Patients With Inducible Ischemia After Thrombolysis in Acute Myocardial Infarction (DANAMI). Circulation 1997; 96: 748-55.Madsen JK, Grande P, Saunamßki K, et al. Danish Multicenter Randomized Study of Invasive Versus Conservative Treatment in Patients With Inducible Ischemia After Thrombolysis in Acute Myocardial Infarction (DANAMI). Circulation 1997; 96: 748-55.Yang EH, Barsness GW, Gersh BJ, et al. Current and Future Treatment Strategies for Refractory Angina. Mayo Clin Proc 2004; 79: 1284-92.Yang EH, Barsness GW, Gersh BJ, et al. Current and Future Treatment Strategies for Refractory Angina. Mayo Clin Proc 2004; 79: 1284-92.Frazier OH, March RJ, Horvath KA. Transmyocardial Revascularization with a Carbon Dioxide Laser in Patients with End-Stage Coronary Artery Disease. N Engl J Med 1999; 341: 1021-8.Frazier OH, March RJ, Horvath KA. Transmyocardial Revascularization with a Carbon Dioxide Laser in Patients with End-Stage Coronary Artery Disease. N Engl J Med 1999; 341: 1021-8.Allen KB, Dowling RD, Fudge TL, et al. Comparison of Transmyocardial Revascularization with Medical Therapy in Patients with Refractory Angina. N Engl J Med 1999; 341: 1029-36.Allen KB, Dowling RD, Fudge TL, et al. Comparison of Transmyocardial Revascularization with Medical Therapy in Patients with Refractory Angina. N Engl J Med 1999; 341: 1029-36.Allen KB, Dowling RD, Angell WW, et al. Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial. Ann Thorac Surg 2004; 77: 1228-34.Allen KB, Dowling RD, Angell WW, et al. Transmyocardial revascularization: 5-year follow-up of a prospective, randomized multicenter trial. Ann Thorac Surg 2004; 77: 1228-34.Aaberge L, Rootwelt K, Blomhoff S, et al. Continued symptomatic improvement three to five years after transmyocardial revascularization with CO (2) laser: a late clinical followup of the Norwegian Randomized trial with transmyocardial revascularization. JACC 2002; 39: 1588-93.Aaberge L, Rootwelt K, Blomhoff S, et al. Continued symptomatic improvement three to five years after transmyocardial revascularization with CO (2) laser: a late clinical followup of the Norwegian Randomized trial with transmyocardial revascularization. JACC 2002; 39: 1588-93.Hattler BG, Griffith BP, Zenati MA, et al. Transmyocardial laser revascularization in the patient with unmanageable unstable angina. Ann Thorac Surg 1999; 68: 1203-9.Hattler BG, Griffith BP, Zenati MA, et al. Transmyocardial laser revascularization in the patient with unmanageable unstable angina. Ann Thorac Surg 1999; 68: 1203-9.Leon MB, Kornowski R, Downey WE, et al. A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease. JACC 2005; 46: 1812-9.Leon MB, Kornowski R, Downey WE, et al. A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease. JACC 2005; 46: 1812-9.Murray S, Collins PD, James MA. Neurostimulation treatment for angina pectoris. Heart 2000; 83: 217-20.Murray S, Collins PD, James MA. Neurostimulation treatment for angina pectoris. Heart 2000; 83: 217-20.Lapenna E, Rapati D, Cardano P, et al. Spinal Cord Stimulation for Patients With Refractory Angina and Previous Coronary Surgery. Ann Thorac Surg 2006; 82: 1704-8.Lapenna E, Rapati D, Cardano P, et al. Spinal Cord Stimulation for Patients With Refractory Angina and Previous Coronary Surgery. Ann Thorac Surg 2006; 82: 1704-8.Mannheimer E, Eliasson T, Augustinsson L, et al. Electrical Stimulation Versus Coronary Artery Bypass Surgery in Severe Angina Pectoris: The ESBY Study. Circulation 1998; 97: 1157-63.Mannheimer E, Eliasson T, Augustinsson L, et al. Electrical Stimulation Versus Coronary Artery Bypass Surgery in Severe Angina Pectoris: The ESBY Study. Circulation 1998; 97: 1157-63.Ekre O, Eliasson T, Norrsell H, et al. Long-term effects of spinal cord stimulation and coronary artery bypass grafting on qualitr of life and survival in the ESBY study. Eur Heart J 2002; 23: 1938-45.Ekre O, Eliasson T, Norrsell H, et al. Long-term effects of spinal cord stimulation and coronary artery bypass grafting on qualitr of life and survival in the ESBY study. Eur Heart J 2002; 23: 1938-45.McNab D, Khan SN, Sharples LD, et al. An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPIRIT trial. Eur Heart J 2006; 27: 1048-53.McNab D, Khan SN, Sharples LD, et al. An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPIRIT trial. Eur Heart J 2006; 27: 1048-53.Gibbons J, Abrams J, Chatterjee K, et al. ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina-Summary Article. Circulation 2003; 107: 149-58.Gibbons J, Abrams J, Chatterjee K, et al. ACC/AHA 2002 Guideline Update for the Management of Patients With Chronic Stable Angina-Summary Article. Circulation 2003; 107: 149-58.Henry TD, Annex BH, McKendall GR, et al. The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis. Circulation 2003; 107: 1359-65.Henry TD, Annex BH, McKendall GR, et al. The VIVA Trial: Vascular Endothelial Growth Factor in Ischemia for Vascular Angiogenesis. Circulation 2003; 107: 1359-65.Simons Michael, Annex BH, Laham RJ, et al. Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial. Circulation 2002; 105: 788-93.Simons Michael, Annex BH, Laham RJ, et al. Pharmacological Treatment of Coronary Artery Disease With Recombinant Fibroblast Growth Factor-2: Double-Blind, Randomized, Controlled Clinical Trial. Circulation 2002; 105: 788-93.Laham RJ, Sellke FW, Edelman ER, et al. Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass Surgery: Results of a Phase I Randomized, Double-Blind, Placebo-Controlled Trial. Circulation 1999; 100: 1865-71.Laham RJ, Sellke FW, Edelman ER, et al. Local Perivascular Delivery of Basic Fibroblast Growth Factor in Patients Undergoing Coronary Bypass Surgery: Results of a Phase I Randomized, Double-Blind, Placebo-Controlled Trial. Circulation 1999; 100: 1865-71.Ruel M, Laham RJ, Parker JA, et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg 2002; 124: 28-34.Ruel M, Laham RJ, Parker JA, et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg 2002; 124: 28-34.Grines CL, Watkins MW, Helmer G, et al. Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris. Circulation 2002; 105: 1291-7.Grines CL, Watkins MW, Helmer G, et al. Angiogenic Gene Therapy (AGENT) Trial in Patients With Stable Angina Pectoris. Circulation 2002; 105: 1291-7.Grines CL, Watkins MW, Mahmarian JJ, et al. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. JACC 2003; 42: 1339-47.Grines CL, Watkins MW, Mahmarian JJ, et al. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. JACC 2003; 42: 1339-47.Santa-Cruz R., Cohen MG, Ohman EM.Aortic Counterpulsation: a Review of the Hemodynamic Effects and Indications for Use. Cathetherization and Cardiovascular Interventions 2006; 67: 68-77.Santa-Cruz R., Cohen MG, Ohman EM.Aortic Counterpulsation: a Review of the Hemodynamic Effects and Indications for Use. Cathetherization and Cardiovascular Interventions 2006; 67: 68-77.Lam L, Mahmood S. Enhanced External Counterpulsation. Asian Cardiovasc Thorac Ann 2003; 11: 92-4.Lam L, Mahmood S. Enhanced External Counterpulsation. Asian Cardiovasc Thorac Ann 2003; 11: 92-4.Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure. JACC 2007; 50: 1523-31.Manchanda A, Soran O. Enhanced external counterpulsation and future directions: step beyond medical management for patients with angina and heart failure. JACC 2007; 50: 1523-31.Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. JACC 1999; 33: 1833-40.Arora RR, Chou TM, Jain D, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. JACC 1999; 33: 1833-40.Taguchi I, Ogawa K, Kanaya T, et al. Effects of Enhanced External Counterpulsation on Hemodynamics and Its Mechanism. Relation to Neurohumoral Factors. Circ J 2004; 68: 1030-4.Taguchi I, Ogawa K, Kanaya T, et al. Effects of Enhanced External Counterpulsation on Hemodynamics and Its Mechanism. Relation to Neurohumoral Factors. Circ J 2004; 68: 1030-4.Cohen J, Grossman W, Michaels AD. Portable enhanced external counterpulsation for acute coronary syndrome and cardiogenic shock: a pilot study. Clin Cardiol 2007; 30: 223-8.Cohen J, Grossman W, Michaels AD. Portable enhanced external counterpulsation for acute coronary syndrome and cardiogenic shock: a pilot study. Clin Cardiol 2007; 30: 223-8.

The authors declare that there are no conflicts of interest present.